{"id":"W4225004644","doi":"10.1007/s41669-022-00331-9","title":"Cost Effectiveness of Subcutaneous Vedolizumab for Maintenance Treatment of Ulcerative Colitis in Canada","year":2022,"lang":"en","type":"article","venue":"PharmacoEconomics - Open","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":11,"is_retracted":false,"has_abstract":true,"ca_institutions":"McMaster University; Population Health Research Institute; Takeda (Canada)","funders":"","keywords":"Vedolizumab; Medicine; Tofacitinib; Golimumab; Ustekinumab; Ulcerative colitis; Infliximab; Adalimumab; Internal medicine; Disease","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001915521,0.0001111262,0.0002371559,0.00002345677,0.00004886609,0.000006701345,0.0002935041,0.00001582519,0.00008058352],"category_scores_gemma":[0.00001169007,0.0001285466,0.00005797929,0.00002551739,0.00002855374,0.000004814948,0.0001634787,0.00002767617,3.977001e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008412162,"about_ca_system_score_gemma":0.001689186,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.1733308,"about_ca_topic_score_gemma":0.3700286,"domain_scores_codex":[0.9991375,0.000165479,0.0002488662,0.0002359843,0.00003696727,0.0001752312],"domain_scores_gemma":[0.9995125,0.00006053606,0.0001499184,0.0001756104,0.00004680161,0.00005463793],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"simulation_or_modeling","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.2533408,0.00306834,0.1053799,0.001522298,0.002687319,0.001577517,0.001590183,0.2957427,0.2853504,0.00547363,0.01338921,0.03087764],"study_design_scores_gemma":[0.03135584,0.002300237,0.1171165,0.00004552856,0.00014513,0.0001027938,0.001126924,0.007563861,0.7597343,0.0004750227,0.07910313,0.0009307169],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9948163,0.00005451799,0.00003036909,0.00003057788,0.0001775709,0.002008783,0.002313679,9.721439e-7,0.0005672532],"genre_scores_gemma":[0.9983182,0.00005356915,0.00004970385,0.00009698474,0.00001956076,0.001104972,0.0002385239,0.00001866412,0.00009983651],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.4743839,"threshold_uncertainty_score":0.8321741,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.023059148200213,"score_gpt":0.3108708866433255,"score_spread":0.2878117384431125,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}